Clinical trial
Effect of Tranexamic Acid (TXA) Administered Prior to Shoulder Arthroscopy on Postoperative Pain Medication Usage: A Randomized Controlled Trial
NCT06920264 is registered in ClinicalTrials.gov with St. Louis Joint Replacement Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Tranexamic Acid (TXA) Administered Prior to Shoulder Arthroscopy on Postoperative Pain Medication Usage: A Randomized Controlled Trial
- Lead sponsor
- St. Louis Joint Replacement Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 1, 2021
- Completion date
- September 30, 2024
- Enrollment
- 165 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
this study will evaluate whether txa reduces pain